Hodgkin lymphoma trials in Kazakhstan

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  PD-1 Inhibitors Maintenance for cHL Post-autoHCT

  Where

  Astana

  Age

  18 years to 70 years

  People

  83 worldwide

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06812858